The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Lungs in Vitro Model-Global Market Insights and Sales Trends 2024
Synopsis
Lungs in Vitro is applied for Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, and Regenerative Medicine. It include four types that are 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, and Inhouse 3D Cell Models
The global Lungs in Vitro Model market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Lungs in Vitro Model in various end use industries. The expanding demands from the Drug Discovery and Toxicology, 3D Model Development, Basic Research and Physiological Research, are propelling Lungs in Vitro Model market. 2D Cell Models, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 3D Cell Models segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Lungs in Vitro Model market, driven by demand from China, the second largest economy with some signs of stabilising, the Lungs in Vitro Model market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lungs in Vitro Model, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lungs in Vitro Model market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lungs in Vitro Model market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lungs in Vitro Model sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lungs in Vitro Model covered in this report include ATCC, Lonza, Epithelix, Mattek, Emulate, Mimetas, Tissuse, Insphero and Cn Bio, etc.
The global Lungs in Vitro Model market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ATCC
Lonza
Epithelix
Mattek
Emulate
Mimetas
Tissuse
Insphero
Cn Bio
AlveoliX
Oncotheis
Global Lungs in Vitro Model market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lungs in Vitro Model market, Segment by Type:
2D Cell Models
3D Cell Models
Global Lungs in Vitro Model market, by Application
Drug Discovery and Toxicology
3D Model Development
Basic Research
Physiological Research
Stem Cell Research and Regenerative Medicine
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lungs in Vitro Model companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Lungs in Vitro is applied for Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, and Regenerative Medicine. It include four types that are 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, and Inhouse 3D Cell Models
The global Lungs in Vitro Model market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Lungs in Vitro Model in various end use industries. The expanding demands from the Drug Discovery and Toxicology, 3D Model Development, Basic Research and Physiological Research, are propelling Lungs in Vitro Model market. 2D Cell Models, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 3D Cell Models segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Lungs in Vitro Model market, driven by demand from China, the second largest economy with some signs of stabilising, the Lungs in Vitro Model market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Lungs in Vitro Model, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Lungs in Vitro Model market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Lungs in Vitro Model market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Lungs in Vitro Model sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Lungs in Vitro Model covered in this report include ATCC, Lonza, Epithelix, Mattek, Emulate, Mimetas, Tissuse, Insphero and Cn Bio, etc.
The global Lungs in Vitro Model market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ATCC
Lonza
Epithelix
Mattek
Emulate
Mimetas
Tissuse
Insphero
Cn Bio
AlveoliX
Oncotheis
Global Lungs in Vitro Model market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Lungs in Vitro Model market, Segment by Type:
2D Cell Models
3D Cell Models
Global Lungs in Vitro Model market, by Application
Drug Discovery and Toxicology
3D Model Development
Basic Research
Physiological Research
Stem Cell Research and Regenerative Medicine
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Lungs in Vitro Model companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Lungs in Vitro Model
1.1 Lungs in Vitro Model Market Overview
1.1.1 Lungs in Vitro Model Product Scope
1.1.2 Lungs in Vitro Model Market Status and Outlook
1.2 Global Lungs in Vitro Model Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Lungs in Vitro Model Market Size by Region (2018-2029)
1.4 Global Lungs in Vitro Model Historic Market Size by Region (2018-2023)
1.5 Global Lungs in Vitro Model Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Lungs in Vitro Model Market Size (2018-2029)
1.6.1 North America Lungs in Vitro Model Market Size (2018-2029)
1.6.2 Europe Lungs in Vitro Model Market Size (2018-2029)
1.6.3 Asia-Pacific Lungs in Vitro Model Market Size (2018-2029)
1.6.4 Latin America Lungs in Vitro Model Market Size (2018-2029)
1.6.5 Middle East & Africa Lungs in Vitro Model Market Size (2018-2029)
2 Lungs in Vitro Model Market by Type
2.1 Introduction
2.1.1 2D Cell Models
2.1.2 3D Cell Models
2.2 Global Lungs in Vitro Model Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Lungs in Vitro Model Historic Market Size by Type (2018-2023)
2.2.2 Global Lungs in Vitro Model Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Lungs in Vitro Model Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Lungs in Vitro Model Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Lungs in Vitro Model Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Lungs in Vitro Model Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Lungs in Vitro Model Revenue Breakdown by Type (2018-2029)
3 Lungs in Vitro Model Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery and Toxicology
3.1.2 3D Model Development
3.1.3 Basic Research
3.1.4 Physiological Research
3.1.5 Stem Cell Research and Regenerative Medicine
3.2 Global Lungs in Vitro Model Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Lungs in Vitro Model Historic Market Size by Application (2018-2023)
3.2.2 Global Lungs in Vitro Model Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Lungs in Vitro Model Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Lungs in Vitro Model Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Lungs in Vitro Model Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Lungs in Vitro Model Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Lungs in Vitro Model Revenue Breakdown by Application (2018-2029)
4 Lungs in Vitro Model Competition Analysis by Players
4.1 Global Lungs in Vitro Model Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lungs in Vitro Model as of 2022)
4.3 Date of Key Players Enter into Lungs in Vitro Model Market
4.4 Global Top Players Lungs in Vitro Model Headquarters and Area Served
4.5 Key Players Lungs in Vitro Model Product Solution and Service
4.6 Competitive Status
4.6.1 Lungs in Vitro Model Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 ATCC
5.1.1 ATCC Profile
5.1.2 ATCC Main Business
5.1.3 ATCC Lungs in Vitro Model Products, Services and Solutions
5.1.4 ATCC Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.1.5 ATCC Recent Developments
5.2 Lonza
5.2.1 Lonza Profile
5.2.2 Lonza Main Business
5.2.3 Lonza Lungs in Vitro Model Products, Services and Solutions
5.2.4 Lonza Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.2.5 Lonza Recent Developments
5.3 Epithelix
5.3.1 Epithelix Profile
5.3.2 Epithelix Main Business
5.3.3 Epithelix Lungs in Vitro Model Products, Services and Solutions
5.3.4 Epithelix Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.3.5 Mattek Recent Developments
5.4 Mattek
5.4.1 Mattek Profile
5.4.2 Mattek Main Business
5.4.3 Mattek Lungs in Vitro Model Products, Services and Solutions
5.4.4 Mattek Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.4.5 Mattek Recent Developments
5.5 Emulate
5.5.1 Emulate Profile
5.5.2 Emulate Main Business
5.5.3 Emulate Lungs in Vitro Model Products, Services and Solutions
5.5.4 Emulate Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.5.5 Emulate Recent Developments
5.6 Mimetas
5.6.1 Mimetas Profile
5.6.2 Mimetas Main Business
5.6.3 Mimetas Lungs in Vitro Model Products, Services and Solutions
5.6.4 Mimetas Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.6.5 Mimetas Recent Developments
5.7 Tissuse
5.7.1 Tissuse Profile
5.7.2 Tissuse Main Business
5.7.3 Tissuse Lungs in Vitro Model Products, Services and Solutions
5.7.4 Tissuse Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.7.5 Tissuse Recent Developments
5.8 Insphero
5.8.1 Insphero Profile
5.8.2 Insphero Main Business
5.8.3 Insphero Lungs in Vitro Model Products, Services and Solutions
5.8.4 Insphero Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.8.5 Insphero Recent Developments
5.9 Cn Bio
5.9.1 Cn Bio Profile
5.9.2 Cn Bio Main Business
5.9.3 Cn Bio Lungs in Vitro Model Products, Services and Solutions
5.9.4 Cn Bio Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.9.5 Cn Bio Recent Developments
5.10 AlveoliX
5.10.1 AlveoliX Profile
5.10.2 AlveoliX Main Business
5.10.3 AlveoliX Lungs in Vitro Model Products, Services and Solutions
5.10.4 AlveoliX Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.10.5 AlveoliX Recent Developments
5.11 Oncotheis
5.11.1 Oncotheis Profile
5.11.2 Oncotheis Main Business
5.11.3 Oncotheis Lungs in Vitro Model Products, Services and Solutions
5.11.4 Oncotheis Lungs in Vitro Model Revenue (US$ Million) & (2018-2023)
5.11.5 Oncotheis Recent Developments
6 North America
6.1 North America Lungs in Vitro Model Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Lungs in Vitro Model Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Lungs in Vitro Model Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Lungs in Vitro Model Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Lungs in Vitro Model Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Lungs in Vitro Model Market Dynamics
11.1 Lungs in Vitro Model Industry Trends
11.2 Lungs in Vitro Model Market Drivers
11.3 Lungs in Vitro Model Market Challenges
11.4 Lungs in Vitro Model Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
